CORona (COVID-19) Follow Up Study: Epidemiology, Pathophysiology, Prediction, and Communication

CompletedOBSERVATIONAL
Enrollment

4,291

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

January 1, 2024

Study Completion Date

November 1, 2024

Conditions
COVID-19Long COVIDPost COVID-19 Condition
Interventions
OTHER

no intervention, the CORFU study conducts analyses based on data which has been prospectively collected (and aggregated when possible) in 7 existing cohorts

(Clinical) baseline and follow-up data will be collected in the 7 existing cohorts. These data will be aggregated (when possible). The CORFU analyses will be conducted based on the aggregated data.

Trial Locations (1)

6229HX

Maastricht University Medical Center+, Maastricht

All Listed Sponsors
collaborator

Zuyderland Medical Centre

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

UMC Utrecht

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

Amsterdam University Medical Center

OTHER

collaborator

Adelante, Centre of Expertise in Rehabilitation and Audiology

OTHER

lead

Maastricht University Medical Center

OTHER

NCT05240742 - CORona (COVID-19) Follow Up Study: Epidemiology, Pathophysiology, Prediction, and Communication | Biotech Hunter | Biotech Hunter